How quickly could you react if a key supplier had an inventory shortage that impacts your product supply? What if you could see these changes in your supply chain daily? Or even weeks in advance? For global pharmaceutical manufacturers, getting a product to market starts with cutting edge research & development and ends with world-class sales. But, sustainable and scalable success requires managing and navigating complex global supply chains, a myriad of regulatory processes, and local market conditions.
Obtaining the data necessary to measure and optimize supply chain performance issues is key to company success, and in many cases, determines whether critical, sometimes life-saving drugs, are delivered to patients on time. Today’s Outlier story involves a global pharmaceutical company that manufactures a Chemotherapy drug essential to treating cancer patients.
Spike in ‘Time to Dispense’ leads to a poor patient experience
During the first week of March, Outlier delivered a story to the Oncology customer that indicated a spike in ‘Average Time to Dispense’ for the Great Plains District. Typically, the number of days it takes to get a drug to a patient is no more than twelve. On March 2, however, that number spiked to nineteen. These extra seven days meant that patients had to wait longer for their therapy, and the manufacturer lost revenue. This is an impactful insight for the pharmaceutical company because it identified the supply chain delay and pinpointed which distributor was contributing to the delay. With this overnight insight from Outlier, the pharmaceutical leader was able to re-direct supply to the Great Plains District and resolve the issue overnight.
Without Outlier, these kinds of insights could require hours, days, or weeks of analysis. Outlier empowers businesses to take a deeper look at their data and uncover unexpected trends that can lead to revenue increases. Sign up for a custom demo to see how a global pharmaceutical company identifies a supply chain delay.